news & events
-
ESMO 2023 – DR. CROOK PRESENTS TOGETHER WITH DATAR CANCER GENETICS
We are delighted to announce that Dr Timothy Crook, Consultant Medical Oncologist at Cromwell Hospital, is presenting alongside international colleagues at the European Society for Medical Oncology (ESMO) in October, 2023.
-
FURTHER BREAKTHROUGH DEVICE DESIGNATION FROM THE FDA
A prospective, blind study was conducted at Imperial College London to provide clinical evidence. In two case-controlled studies, a 98% sensitivity and specificity in the detection of malignant brain tumours and in the differentiation between malignant and benign CNS diseases was established.
-
RENOWNED ASSIGNMENT TO THE SCIENTIFIC ADVISORY BOARD OF DATAR CANCER GENETICS
We are pleased to announce that Dr Massimo Cristofanilli, Dr Razelle Kurzrock as well as Prof Sendurai Mani have agreed to join our Scientific Advisory Board.
-
PROMISING INITIAL STUDY RESULTS IN THE DETECTION OF GLIAL MALIGNANCIES USING GLIAL CELLS IN THE BLOOD
This research explores the effectiveness of identifying glial malignancies through the enrichment and detection of circulating glial cells (CGCs) in peripheral blood as a rapid and straightforward diagnostic stratagem for these patients.
-
HOT NEWS! OUR LATEST PUBLICATION IN FRONTIERS IN MEDICINE
The case study demonstrates that individuals with uncommon tumor types can experience advantages from an expanded molecular-genetic tumor profile.
-
MKOT – PRECISION ONCOLOGY SYMPOSIUM SEPT. 2021
In September 2021, Dr. Stefan Schuster delivered a presentation during the MKOT Symposium.
CONTACT
Cancer Profiling Australia
903/50 Clarence Street,
SYDNEY NSW 2000
PH +61 1300 282 482
FAX +61 2 8088 7097
Email: info@cancerprofiling.com.au